146 related articles for article (PubMed ID: 31869601)
1. Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.
Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L
Drug Alcohol Depend; 2020 Jan; 206():107697. PubMed ID: 31869601
[TBL] [Abstract][Full Text] [Related]
2. Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.
Peacock A; Larance B; Farrell M; Cairns R; Buckley N; Degenhardt L
BMJ Open; 2018 Mar; 8(3):e020006. PubMed ID: 29574444
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
Vosburg SK; Severtson SG; Dart RC; Cicero TJ; Kurtz SP; Parrino MW; Green JL
J Pain; 2018 Apr; 19(4):439-453. PubMed ID: 29224919
[TBL] [Abstract][Full Text] [Related]
5. Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study.
Black J; Margolin ZR; Bau G; Olson R; Iwanicki JL; Dart RC
JMIR Public Health Surveill; 2021 Dec; 7(12):e29187. PubMed ID: 34932012
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids.
Lam T; Hayman J; Berecki-Gisolf J; Sanfilippo P; Lubman DI; Nielsen S
Addiction; 2022 Mar; 117(3):623-636. PubMed ID: 34338377
[TBL] [Abstract][Full Text] [Related]
7. The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.
Larance B; Dobbins T; Peacock A; Ali R; Bruno R; Lintzeris N; Farrell M; Degenhardt L
Lancet Psychiatry; 2018 Feb; 5(2):155-166. PubMed ID: 29336948
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical opioid use among oral and intravenous users in Australia: A qualitative comparative study.
Dertadian G; Iversen J; Dixon TC; Sotiropoulos K; Maher L
Int J Drug Policy; 2017 Mar; 41():51-58. PubMed ID: 28107670
[TBL] [Abstract][Full Text] [Related]
9. Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment.
Butler SF; McNaughton EC; Black RA
Pain Med; 2015 Jan; 16(1):119-30. PubMed ID: 25243972
[TBL] [Abstract][Full Text] [Related]
10. Injection drug use and overdose among young adults who use prescription opioids non-medically.
Liebling EJ; Green TC; Hadland SE; Marshall BDL
Addict Behav; 2018 Jan; 76():20-26. PubMed ID: 28735037
[TBL] [Abstract][Full Text] [Related]
11. Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia.
Sutherland R; Dietze PM; Gisev N; Bruno R; Campbell G; Memedovic S; Peacock A
Drug Alcohol Rev; 2020 Jul; 39(5):568-574. PubMed ID: 32557912
[TBL] [Abstract][Full Text] [Related]
12. Intravenous fentanyl use among people who inject drugs in Australia.
Geddes L; Iversen J; Memedovic S; Maher L
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S314-S322. PubMed ID: 29405465
[TBL] [Abstract][Full Text] [Related]
13. Prescription opioid use and non-fatal overdose in a cohort of injection drug users.
Lake S; Wood E; Buxton J; Dong H; Montaner J; Kerr T
Am J Drug Alcohol Abuse; 2015 May; 41(3):257-63. PubMed ID: 25699628
[TBL] [Abstract][Full Text] [Related]
14. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
[TBL] [Abstract][Full Text] [Related]
15. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
16. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
[TBL] [Abstract][Full Text] [Related]
17. Tapentadol abuse and dependence in India.
Mukherjee D; Shukla L; Saha P; Mahadevan J; Kandasamy A; Chand P; Benegal V; Murthy P
Asian J Psychiatr; 2020 Mar; 49():101978. PubMed ID: 32120298
[TBL] [Abstract][Full Text] [Related]
18. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.
Lake S; Hayashi K; Buxton J; Milloy MJ; Dong H; Wood E; Montaner J; Kerr T
Drug Alcohol Depend; 2015 Nov; 156():297-303. PubMed ID: 26454837
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index-Multimedia Version (ASI-MV).
Vosburg SK; Beaumont J; Dailey-Govoni ST; Butler SF; Green JL
Pain Med; 2020 Sep; 21(9):1891-1901. PubMed ID: 31617931
[TBL] [Abstract][Full Text] [Related]
20. Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?
Betts KS; McIlwraith F; Dietze P; Whittaker E; Burns L; Cogger S; Alati R
Drug Alcohol Depend; 2015 Sep; 154():76-84. PubMed ID: 26130335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
